Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-27

FDA Approved: PHENYTOIN SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for PHENYTOIN SODIUM from Hikma Pharmaceuticals USA Inc., granting the requested changes under an approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHENYTOIN SODIUM (phenytoin sodium)

Snippet

SUPPL AP for PHENYTOIN SODIUM (PHENYTOIN SODIUM)